1887
  1. Home
  2. Eurosurveillance
  3. Volume 28, Issue 17, 27/Apr/2023
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

Following an increase in diphtheria cases in Europe since 2022, we retrospectively estimated the prevalence of seroprotection against diphtheria and tetanus in 10,247 Austrian residents (population: 8,978,929) voluntarily tested between 2018 and 2022. Lack of seroprotection against diphtheria was found in 36% compared with 4% against tetanus. The geometric mean antibody concentration against tetanus was 7.9-fold higher compared with that for diphtheria. Raising awareness of regular booster vaccinations against diphtheria in combination with tetanus and pertussis is urgently needed.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2023.28.17.2300206
2023-04-27
2024-12-23
/content/10.2807/1560-7917.ES.2023.28.17.2300206
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/28/17/eurosurv-28-17-2.html?itemId=/content/10.2807/1560-7917.ES.2023.28.17.2300206&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). Increase of reported diphtheria cases among migrants in Europe due to Corynebacterium diphtheriae, 2022. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/increase-reported-diphtheria-cases-among-migrants-europe-due-corynebacterium
  2. Berbers G, van Gageldonk P, Kassteele JV, Wiedermann U, Desombere I, Dalby T, et al. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries. Nat Commun. 2021;12(1):2871.  https://doi.org/10.1038/s41467-021-23114-y  PMID: 34001895 
  3. Plotkin SA. Recent updates on correlates of vaccine-induced protection. Front Immunol. 2023;13:1081107.  https://doi.org/10.3389/fimmu.2022.1081107  PMID: 36776392 
  4. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17(7):1055-65.  https://doi.org/10.1128/CVI.00131-10  PMID: 20463105 
  5. Sison CP, Glaz J. Simultaneous confidence intervals and sample size determination for multinomial proportions. J Am Stat Assoc. 1995;90(429):366-9.  https://doi.org/10.1080/01621459.1995.10476521 
  6. Efstratiou A, Maple C. Manual for the laboratory diagnosis of diphtheria. Copenhagen: World Health Organization Regional Office for Europe; 1994. Available from: https://apps.who.int/iris/bitstream/handle/10665/108108/ICP_EPI_038_%28C%29.pdf?sequence=1&isAllowed=y
  7. Österreichische Agentur für Gesundheit und Ernährungssicherheit (AGES). Diphtherie - Corynebacterium diphtheriae 2023. [Diphtheria Corynebacterium diphtheriae]. Vienna: AGES. [Accessed: 4 Apr 2023]. German. Available from: https://www.ages.at/mensch/krankheit/krankheitserreger-von-a-bis-z/diphtherie
  8. WorldAtlas. DPT immunization rates by country. 5 Nov 2019. Available from: https://www.worldatlas.com/articles/immunization-against-preventable-disease-the-highest-rates-of-youth-vaccination-worldwide.html
  9. United Nations Children's Fund (UNICEF). Immunization and conflict. New York: UNICEF. [Accessed: 4 Apr 2023]. Available from: https://www.unicef.org/immunization/immunization-and-conflict
  10. Muscat M, Gebrie B, Efstratiou A, Datta SS, Daniels D. Diphtheria in the WHO European Region, 2010 to 2019. Euro Surveill. 2022;27(8):2100058.  https://doi.org/10.2807/1560-7917.ES.2022.27.8.2100058  PMID: 35209973 
  11. European Centre for Disease Prevention and Control (ECDC). Weekly threats reports (CDTR). Communicable disease threats reports. Stockholm: ECDC. [Accessed: 12 Apr 2023]. Available from: https://www.ecdc.europa.eu/en/publications-and-data/monitoring/weekly-threats-reports
  12. United States Centers for Disease Control and Prevention (CDC). Diphtheria vaccination. Atlanta: CDC. [Accessed: 12 Apr 2023]. Available from: https://www.cdc.gov/vaccines/vpd/diphtheria/index.html
  13. Cheuvart B, Burgess M, Zepp F, Mertsola J, Wolter J, Schuerman L. Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model. Vaccine. 2004;23(3):336-42.  https://doi.org/10.1016/j.vaccine.2004.06.012  PMID: 15530678 
  14. Federal Ministry Republic of Austria for Social Affairs, Health, Care and Consumer Protection. Austrian national immunization plan 2023. Vienna: Austrian government. [Accessed: 12 Apr 2023]. Available from: https://www.sozialministerium.at/Themen/Gesundheit/Impfen/Impfplan-%C3%96sterreich.html
Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Angelika+Wagner&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Wagner Angelika</a>, <a href="/search?value1=Joanna+Jasinska&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jasinska Joanna</a>, <a href="/search?value1=Daniela+Schmid&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schmid Daniela</a>, <a href="/search?value1=Michael+Kundi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kundi Michael</a>, <a href="/search?value1=Ursula+Wiedermann&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Wiedermann Ursula</a></span>. Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022 . <a href="/content/ecdc">Euro Surveill.</a> 2023;28(17):pii=2300206. <a href="https://doi.org/10.2807/1560-7917.ES.2023.28.17.2300206" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2023.28.17.2300206</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 06 Apr 2023;&nbsp;&nbsp; <span class="generated">Accepted</span>: 26 Apr 2023 </span> </p>
/content/10.2807/1560-7917.ES.2023.28.17.2300206
/content/10.2807/1560-7917.ES.2023.28.17.2300206
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error